MassDevice

In this episode of the #DeviceTalksWeekly Podcast, MassDevice Editor Chris Newmarker sits down with Wayne Paterson, CEO of Anteris Technologies, a unique start-up that��s approaching the complicated & competitive #TAVR market. Chris Newsmaker & Host Tom Salemi also discuss this week��s Newmarker��s Newsmakers, including news from; Medtronic, Boston Scientific, Johnson & Johnson MedTech, NeuroPace, & the FDA. This episode was sponsored by DeviceTalks Minnesota. Register to attend the June 11 event at Minnesota.DeviceTalks.com. LISTEN HERE: https://lnkd.in/eeTt-5-U #StructuralHeart #HeartValve #AorticValve #Cardiac

Come meet with our editors Chris Newmarker and Sean Whooley at DeviceTalks Boston! Chris and Sean will be leading conversations and soaking up #MedTech industry insights. Be part of it! And register before midnight ET tonight to secure our Early Bird registration!!!

Just 12 hours left to save ?????????? on your #DeviceTalksBoston registeration. We've lined up some amazing stories and lessons to share starting with our amazing keynote interviews, presentations and panels. ?Ivan Tornos, Zimmer Biomet ?Kurt Cannon, Olympus Corporation of the Americas ?Julie Cole, Medtronic ?Charisse Y. Sparks, M.D., FAAOS, Inspire Medical Systems ?Ann Marie Joyce, MD ?Cecilia Soriano, Baxter International Inc. ?Scott Fraser, Fraser Healthcare ?Tracy Warren, American Heart Association DeviceTalks MassDevice

This has been a tough month when it comes to #layoffs in the Southern California #medtech #meddevice hub. We have news today on Medical Tubing + Extrusion and MassDevice about Adagio Medical Inc. (Laguna Hills) announcing job cuts. Plus, we have a story on MassDevice about WARN reports filed by STAAR Surgical, BD, and Acutus Medical, Inc. (I'll include links in the comments below.)

In the DeviceTalks Weekly Podcast that will drop later today, Jim Hammerand, Chris Newmarker, and I covered the Great #MedTech Re-Sort (not resort) that we've been seeing in 2025. I pulled these headlines/deals from my notes. Amazing amount of refocusing and redirection going on. I don't have a reason why other than the abundance and hunger of #privateequity and growing demand from #shareholders for higher growth. Open to hearing from others. Again, this is all from 2025 including today's news from MassDevice's Sean Whooley ??Owens & Minor is in talks to sell Products & Healthcare Services segment ??Teleflex to separate into two publicly traded companies ??Solventum to sell Purification and Filtration business for $4.1B ??Fresenius Medical Care divests some lab assets to Quest Diagnostics ??Johnson & Johnson MedTech reportedly wants to sell its Cerenovus stroke business for $1B ??Dentsply Sirona to consider strategic alternatives for Wellspect Healthcare business ??BD announces intent to sell Life Sciences business, beats Street in Q1 ??Baxter International Inc. CEO Almeida to retire, Kidney Care business becomes standalone company ??Stryker will sell spine implant business; CFO set to retire ??Philips is selling its Emergency Care business to private equity ?? Bioventus divests Advanced Rehabilitation business to PE firm

Teleflex stock lost a fifth of its value today after it announced a Q4 revenue miss, plans to split up the company, an acquisition from BIOTRONIK, and its CFO's plans to retire. That's a lot to unpack, and Associate Editor Sean Whooley goes through it all in detail on MassDevice. (I'll include a link in the comments below.) #medtech #meddevice

Medtronic?says investigators enrolled the first patient in a pivotal trial of its Prevail drug-coated balloon (DCB). ��This trial will not only bring the use of this innovative DCB technology to patients with previously treated blockages �� where stents have failed �� but it will also bring use to new blockages in small vessels �� where stents might not perform as well in the coronary arteries." We have more on Medical Tubing + Extrusion and MassDevice. (I'll include the MT+E link in the comments.) #medtech #meddevice #cardiovascular

He was one of Johnson & Johnson's top executives in China for over 20 years, and now he's going to be GE HealthCare's China CEO. We have the details on MassDevice. #medtech #meddevice #China

This morning brings news of some significant shifts in #medtech, specifically at two companies: Teleflex today announced its plan to separate into two separate, publicly traded businesses. "NewCo" includes the company's Urology, Acute Care and OEM businesses. ��RemainCo�� consists of the Teleflex Vascular Access, Interventional and Surgical businesses. Teleflex also shared its fourth-quarter results and announced the retirement of a longtime executive. Meanwhile, Biotronik is shifting its strategy. That includes the divestiture of its Vascular Interventions business to (none other than) Teleflex. More on that in the comments below �� read about all the changes at Teleflex at MassDevice: https://lnkd.in/eVmEue-S

Where do surgical robotics companies stand in their funding journey? We asked surgical robotics companies about their funding stage; the results were wide-ranging. Of the companies that disclosed that info to us, here's what we found: 13 companies were revenue-generating. 11 companies were Series C & beyond. 8 companies were Series B. 7 companies were Series A. 1 company was in the seed stage. 1 company is still stealth. 3 listed themselves as other. These insights highlight just a portion of the surgical robotics market, with a mix of established players and growing startups working to advance the field. What do you think these trends say about the future of surgical robotics? Full surgical robotics industry report coming to MassDevice soon. #medtech #medicaldevices #meddevice #robotics #surgicalrobotics